Atea Pharmaceuticals (NASDAQ:AVIR – Get Free Report) and Akebia Therapeutics (NASDAQ:AKBA – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, earnings, analyst recommendations, institutional ownership, profitability, valuation and dividends. Valuation and Earnings This table compares Atea […]
The U.S. Food and Drug
Administration approved Akebia Therapeutics drug to
treat anemia caused by chronic kidney disease in dialysis
patients, the drugmaker said on Wednesday.
(Reporting by Pratik.
(Reuters) - The U.S. Food and Drug Administration approved Akebia Therapeutics' drug to treat anemia caused by chronic kidney disease in dialysis patients, the drugmaker said on Wednesday. (Reporting by Pratik Jain, Vaibhav Sadhamta and Mrinmay De.
Health: US FDA approves Akebia s anaemia drug gdnonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gdnonline.com Daily Mail and Mail on Sunday newspapers.